Neutral sphingomyelinase 2 inhibitors based on the 4-(1H-imidazol-2-yl)-2,6-dialkoxyphenol scaffold.

MLA

Stepanek, Ondrej, et al. “Neutral Sphingomyelinase 2 Inhibitors Based on the 4-(1H-Imidazol-2-Yl)-2,6-Dialkoxyphenol Scaffold.” European Journal of Medicinal Chemistry, vol. 170, May 2019, pp. 276–89. EBSCOhost, https://doi.org/10.1016/j.ejmech.2019.03.015.

APA

Stepanek, O., Hin, N., Thomas, A. G., Dash, R. P., Alt, J., Rais, R., Rojas, C., Slusher, B. S., & Tsukamoto, T. (2019). Neutral sphingomyelinase 2 inhibitors based on the 4-(1H-imidazol-2-yl)-2,6-dialkoxyphenol scaffold. European Journal of Medicinal Chemistry, 170, 276–289. https://doi.org/10.1016/j.ejmech.2019.03.015

Chicago

Stepanek, Ondrej, Niyada Hin, Ajit G Thomas, Ranjeet P Dash, Jesse Alt, Rana Rais, Camilo Rojas, Barbara S Slusher, and Takashi Tsukamoto. 2019. “Neutral Sphingomyelinase 2 Inhibitors Based on the 4-(1H-Imidazol-2-Yl)-2,6-Dialkoxyphenol Scaffold.” European Journal of Medicinal Chemistry 170 (May): 276–89. doi:10.1016/j.ejmech.2019.03.015.